DK0546102T3 - Tropolonderivater og farmaceutisk sammensætning deraf til hindring og behandling af iskæmiske sygdomme - Google Patents
Tropolonderivater og farmaceutisk sammensætning deraf til hindring og behandling af iskæmiske sygdommeInfo
- Publication number
- DK0546102T3 DK0546102T3 DK91917948.1T DK91917948T DK0546102T3 DK 0546102 T3 DK0546102 T3 DK 0546102T3 DK 91917948 T DK91917948 T DK 91917948T DK 0546102 T3 DK0546102 T3 DK 0546102T3
- Authority
- DK
- Denmark
- Prior art keywords
- prevention
- treatment
- pharmaceutical composition
- ischemic diseases
- tropolone derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2229536A JPH04120069A (ja) | 1990-08-29 | 1990-08-29 | トロポロン誘導体およびこれを有効成分とする虚血性疾患の予防・治療剤 |
JP5625291A JPH04247077A (ja) | 1991-01-31 | 1991-01-31 | トロポロン誘導体およびそれを有効成分とする虚血性疾患の予防・治療剤 |
JP3039173A JPH04295471A (ja) | 1991-02-08 | 1991-02-08 | トロポロン誘導体およびこれを有効成分とする虚血性疾患の予防・治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0546102T3 true DK0546102T3 (da) | 1998-06-02 |
Family
ID=27290061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91917948.1T DK0546102T3 (da) | 1990-08-29 | 1991-08-27 | Tropolonderivater og farmaceutisk sammensætning deraf til hindring og behandling af iskæmiske sygdomme |
Country Status (14)
Country | Link |
---|---|
US (1) | US5594144A (da) |
EP (1) | EP0546102B1 (da) |
JP (1) | JP2512656B2 (da) |
KR (1) | KR100232324B1 (da) |
AT (1) | ATE159251T1 (da) |
AU (1) | AU651629B2 (da) |
CA (1) | CA2087004C (da) |
DE (1) | DE69127976T2 (da) |
DK (1) | DK0546102T3 (da) |
ES (1) | ES2109276T3 (da) |
FI (1) | FI930860A (da) |
HU (2) | HUT65943A (da) |
NO (1) | NO305801B1 (da) |
WO (1) | WO1992004338A1 (da) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5703071A (en) * | 1990-08-29 | 1997-12-30 | Pharmacia & Upjohn Company | Tropolone derivatives and pharmaceutical composition thereof for preventing and treating ischemic diseases |
CN1063443C (zh) * | 1995-03-28 | 2001-03-21 | 日本脏器制药株式会社 | 新的苯并噻唑衍生物 |
JP2000516629A (ja) * | 1996-08-22 | 2000-12-12 | ヘキスト・マリオン・ルセル・インコーポレイテツド | 選択的ドーパミンd4受容体リガンドとしてのトロポニルピペラジン |
US5998414A (en) * | 1996-08-22 | 1999-12-07 | Hoechst Marion Roussel, Inc. | Troponyl piperazines as dopamine D4 receptor ligands |
US6221868B1 (en) | 1997-06-27 | 2001-04-24 | Nippon Kayaku Kabushiki Kaisha | Remedies/preventives for frequent urination/urinary incontinence and tropone derivatives |
JP2002531552A (ja) * | 1998-12-04 | 2002-09-24 | ニューロサーチ、アクティーゼルスカブ | イオンチャネル調節剤としての新規ベンズイミダゾロン−、ベンズオキサゾロン−又はベンゾチアゾロン−誘導体 |
IL158631A0 (en) | 2001-05-18 | 2004-05-12 | Astrazeneca Ab | 4-(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
US6689342B1 (en) * | 2002-07-29 | 2004-02-10 | Warner-Lambert Company | Oral care compositions comprising tropolone compounds and essential oils and methods of using the same |
SE0203303D0 (sv) | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
SE0203302D0 (sv) | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
SE0203300D0 (sv) | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
MX2007001240A (es) | 2004-08-02 | 2007-03-23 | Astrazeneca Ab | Derivados de diarilmetil-piperazina, preparaciones y usos de las mismas. |
KR101036322B1 (ko) | 2009-11-12 | 2011-05-23 | 한국과학기술연구원 | 히노키티올의 프롤릴 하이드록실라제 2 활성 저해 용도 |
FR2993462B1 (fr) * | 2012-07-18 | 2014-10-17 | Ct Eugene Marquis | Composition a usage therapeutique comprenant une phrase organique lipidique et un complexe de terre rare radioisotopique |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1153764A (en) * | 1980-02-25 | 1983-09-13 | Jehan F. Bagli | 2-(1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives |
IL94390A (en) * | 1989-05-30 | 1996-03-31 | Merck & Co Inc | The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them |
-
1991
- 1991-08-27 CA CA002087004A patent/CA2087004C/en not_active Expired - Fee Related
- 1991-08-27 DE DE69127976T patent/DE69127976T2/de not_active Expired - Fee Related
- 1991-08-27 WO PCT/US1991/005906 patent/WO1992004338A1/en active IP Right Grant
- 1991-08-27 AT AT91917948T patent/ATE159251T1/de not_active IP Right Cessation
- 1991-08-27 AU AU87203/91A patent/AU651629B2/en not_active Ceased
- 1991-08-27 KR KR1019930700593A patent/KR100232324B1/ko not_active IP Right Cessation
- 1991-08-27 JP JP3516629A patent/JP2512656B2/ja not_active Expired - Lifetime
- 1991-08-27 HU HU9300533A patent/HUT65943A/hu unknown
- 1991-08-27 ES ES91917948T patent/ES2109276T3/es not_active Expired - Lifetime
- 1991-08-27 EP EP91917948A patent/EP0546102B1/en not_active Expired - Lifetime
- 1991-08-27 DK DK91917948.1T patent/DK0546102T3/da active
-
1993
- 1993-02-25 NO NO930669A patent/NO305801B1/no not_active IP Right Cessation
- 1993-02-25 FI FI930860A patent/FI930860A/fi not_active Application Discontinuation
-
1995
- 1995-05-18 US US08/442,710 patent/US5594144A/en not_active Expired - Fee Related
- 1995-06-23 HU HU95P/P00409P patent/HU211307A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
FI930860A0 (fi) | 1993-02-25 |
FI930860A (fi) | 1993-02-25 |
HU9300533D0 (en) | 1993-05-28 |
DE69127976T2 (de) | 1998-03-05 |
NO930669L (no) | 1993-02-25 |
JP2512656B2 (ja) | 1996-07-03 |
AU651629B2 (en) | 1994-07-28 |
ES2109276T3 (es) | 1998-01-16 |
NO930669D0 (no) | 1993-02-25 |
CA2087004A1 (en) | 1992-03-01 |
ATE159251T1 (de) | 1997-11-15 |
JPH06509318A (ja) | 1994-10-20 |
DE69127976D1 (de) | 1997-11-20 |
EP0546102A1 (en) | 1993-06-16 |
NO305801B1 (no) | 1999-07-26 |
CA2087004C (en) | 1998-04-21 |
KR100232324B1 (ko) | 1999-12-01 |
WO1992004338A1 (en) | 1992-03-19 |
HU211307A9 (en) | 1995-11-28 |
EP0546102B1 (en) | 1997-10-15 |
HUT65943A (en) | 1994-08-29 |
AU8720391A (en) | 1992-03-30 |
US5594144A (en) | 1997-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0513543T3 (da) | Amidinophenylalaninderivater, fremgangsmåde til deres fremstilling, deres anvendelse og antikoagulationsmidler med indehold deraf | |
DK0546102T3 (da) | Tropolonderivater og farmaceutisk sammensætning deraf til hindring og behandling af iskæmiske sygdomme | |
SE9002206D0 (sv) | New compounds | |
NO924598D0 (no) | Fremstilling av substituerte piperidiner | |
NO941958D0 (no) | Fremstilling av substituerte piperidiner | |
NO944946D0 (no) | Forgrenet-amino-substituerte tiazoler, fremgangsmåter for fremstilling av dem og farmasöytiske blandinger inneholdende dem | |
DK0714387T3 (da) | Hidtil ukendte bis-naphthalimider til behandling af cancer | |
DE3667059D1 (en) | Benzodipyrroles, processes for their preparation and pharmaceutical compositions containing these compounds | |
ES8205759A1 (es) | Un procedimiento para la preparacion de aminopropenol y pro-pano nitrilos 2 sustituidos. | |
FI852743A0 (fi) | Acetyleniska fenoxipropanolderivat och farmaceutiska kompositioner foer behandling av hypertoni. | |
ES2104174T3 (es) | Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos. | |
DK259589D0 (da) | Joderede, ikke-ioniske trijodbenzenforbindelser og kontrastmiddel indeholdende dem | |
ES8201993A1 (es) | Un procedimiento para la preparacion de tiazoles | |
DE59003446D1 (de) | 13-Brom und 13, 14-Dibrom-Ergoline, ihre Herstellung und Verwendung in Arzneimitteln. | |
SE9203824D0 (sv) | Benzofuranylimidazole derivatives a process for the preparation and therapeutical compositions containing the same | |
ATE120736T1 (de) | Benzylselenobenzamide von aminopyridinen und picolylaminen. | |
IL95384A0 (en) | 1,3-oxazines,their preparation and pharmaceutical compositions containing them | |
SE7909980L (sv) | I-amino-indolin-derivat, deras framstellning och farmaceutiska kompositioner innehallande desamma |